The patient perspective in the era of personalized medicine: What about scanxiety?

被引:17
|
作者
Custers, Jose A. E. [1 ]
Davis, Lucy
Messiou, Christina [2 ]
Prins, Judith B. [1 ]
van der Graaf, Winette T. A. [3 ,4 ]
机构
[1] Radboud Univ Nijmegen Med Ctr, Radboud Inst Hlth Sci, Dept Med Psychol, Nijmegen, Netherlands
[2] Royal Marsden Hosp Fdn Trust & Inst Canc Res, London, England
[3] Erasmus MC, Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands
[4] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
来源
CANCER MEDICINE | 2021年 / 10卷 / 09期
关键词
CANCER RECURRENCE; CLINICAL FEAR; MELANOMA; MEMORY;
D O I
10.1002/cam4.3889
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Frequency of scanning has accelerated in the era of personalized medicine and is related, but not restricted, to the exploding number of clinical trials for new cancer treatments. Particularly in drug trials, but also in clinical practice, patients are followed up by scans frequently, which may vary from every 6 to 12 weeks until progression. The authors aimed to raise awareness for this underreported but widely present "Sword of Damocles" scan-related issue also referred to as 'scanxiety.'
引用
收藏
页码:2943 / 2945
页数:3
相关论文
共 50 条